Clinical Trials Browser

Phase 2 × Interventional × Hyperaldosteronism × Clear all

NCT01867710 2019-07-05

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Phase 2 Completed

164 enrolled 22 charts

Hyperaldosteronism, Prostatic Neoplasms